Table 2.
Acute CSF | Acute Serum | Chronic Serum | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | p | n | p | 6 Months | n | p | 12 Months | n | p | ||||
Age, r | 0.059 | 57 | 0.659 | −0.089 | 49 | 0.543 | −0.168 | 48 | 0.252 | 0.026 | 35 | 0.880 | |
GCS, r | −0.069 | 57 | 0.606 | −0.041 | 49 | 0.780 | 0.211 | 46 | 0.160 | 0.305 | 33 | 0.084 | |
Sex, mean±STD | 0.203 | 0.253 | 0.187 | 0.009 | |||||||||
Male | 0.17±0.07 | 46 | 153.5±41.1 | 43 | 210.2±73.9 | 41 | 201.9±80.2 | 29 | |||||
Female | 0.18±0.06 | 11 | 136.0±24.1 | 6 | 178.3±44.8 | 7 | 124.5±40.7 | 6 | |||||
Education, r | 0.144 | 52 | 0.309 | −0.250 | 42 | 0.110 | −0.009 | 47 | 0.947 | −0.065 | 35 | 0.711 | |
Antidepressants, mean±STD | - | - | 0.111 | 0.415 | |||||||||
No | 220.0±76.2 | 30 | 196.0±81.1 | 23 | |||||||||
Yes | 182.4±38.4 | 11 | 188.0±81.0 | 10 |